PsychonautWiki marks this substance entry as unapproved. Its information may be incomplete or awaiting review.
DMAA
Overview
Also known as methylhexanamine, this sympathetomimetic drug was developed as a nasal decongestant by Eli Lilly in the 1940s. It has been used as a weight loss aid and missold as a dietary supplement and component of some energy drinks. Carries a risk of heart attack, stroke and other life-threatening cardiovascular issues.
Sources & licencesTripSit
TripSit material is used non-commercially with attribution and a link to the source. Where combination information is shown, it is a quick reference and should be checked with further individual research.
- Snapshot
- Bundled snapshot
- Last data refresh
Fracton stores and reformats source data for local, offline display. These source projects do not endorse Fracton.
Tags4 tags
Dose
?
Rapid onset.
Safety
Other stimulants.
- Addiction potential
- habit-forming
Effects
No effects are listed for this substance.
Timing
Only onset and total duration are available for this route, so an intensity curve would be misleading.
Detailed phase timing is not available from this source.
Personal
No personal notes yet. Switch to Edit to add something you want to remember about this substance.
Personal tabs are locked
They use the same encrypted vault and passphrase as your Journal.